https://www.selleckchem.com/products/Y-27632.html
01 at 10years). Five-year survival was significantly better for non-CF females versus CF females (56% vs. 48%, p=.013), but was similar between groups for males (55% vs. 54%, p=.305). While age was a late outcomes risk factor, pulmonary hypertension and later transplants eras were protective. Early mortality is higher and late mortality is lower in non-CF LTx. Current non-CF LTx outcomes leave room for improvement. Further study is needed to evaluate the effects of center volume and pediatric-specific experience on outcomes. Early morta